Kirkland & Ellis, the prominent law firm known for its extensive track record in high-stakes pharmaceutical cases, has withdrawn its representation of Novartis AG in a lawsuit against Regeneron Inc. This sudden exit occurred just one week after the firm faced a challenge regarding a potential conflict of interest.
The withdrawal from the case included Jim Hurst, a notable trial lawyer with significant experience representing pharmaceutical giants. The specific reasons behind Kirkland & Ellis’s decision to step down have not been disclosed, as the motions to withdraw provided no explicit rationale for their departure. Both Kirkland & Ellis and Novartis have yet to provide comments on the situation.
This legal maneuver follows the filing of a motion in the Southern District of New York, where the judge did not make a ruling on the conflict of interest challenge presented by Regeneron’s legal team. With Kirkland & Ellis stepping aside, Novartis is now represented by White & Case in this ongoing litigation.
For further details on the development, you can view the Bloomberg Law article here.